Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer

Autor: Nitz, U. *, Gluz, O., Zuna, I., Oberhoff, C., Reimer, T., Schumacher, C., Hackmann, J., Warm, M., Uleer, C., Runde, V., Dünnebacke, J., Belzl, N., Augustin, D., Kates, R.E., Harbeck, N.
Zdroj: In Annals of Oncology January 2014 25(1):75-80
Databáze: ScienceDirect